CIBC Bancorp USA’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
CIBC Bancorp USA's TGTX Position: Q3 2026 in Review
CIBC Bancorp USA increased its TG Therapeutics (TGTX) stake by 81% in Q3 2026, buying an estimated $366K and bringing the position to 15,089 shares worth $842K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.
CIBC Bancorp USA first reported a position in TGTX in Q3 2025 and has held it in 4 quarters since. 454 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- CIBC Bancorp USA held 15,089 shares of TG Therapeutics worth $842K as of Q3 2026.
- CIBC Bancorp USA bought 6,763 TG Therapeutics shares in Q3 2026, an estimated $366K.
- TG Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1146 holding.
- CIBC Bancorp USA first reported a position in TG Therapeutics in Q3 2025 and has held it in 4 quarters since.
- 454 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.